LEFLUNOMIDE APOTEX leflunomide 20mg tablets blister pack

Country: Аустралија

Језик: Енглески

Извор: Department of Health (Therapeutic Goods Administration)

Активни састојак:

leflunomide, Quantity: 20 mg

Доступно од:

Arrotex Pharmaceuticals Pty Ltd

INN (Међународно име):

Leflunomide

Фармацеутски облик:

Tablet, uncoated

Састав:

Excipient Ingredients: crospovidone; magnesium stearate; colloidal anhydrous silica; lactose

Пут администрације:

Oral

Јединице у пакету:

30 tablets

Тип рецептора:

(S4) Prescription Only Medicine

Терапеутске индикације:

LEFLUNOMIDE APOTEX is indicated for the treatment of: active rheumatoid arthritis; active psoriatic arthritis. GenRx Leflunomide is not indicated for the treatment of psoriasis that is not associated with manifestations of arthritic disease. The combined use of GenRx Leflunomide with other disease modifying antirheumatic drugs (DMARDs) has not been adequately studied (see Precautions).

Резиме производа:

Visual Identification: White, arc-triangular shaped tablet. Engraved "LE" over "20" on one side and "APO" on the other side.; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius

Статус ауторизације:

Registered

Датум одобрења:

2008-07-14